{"schema_version":"secwatch.filing_event.v1","accession":"0001870940-24-000041","form_type":"8-K","ticker":"AIRS","cik":"0001870940","company_name":"Airsculpt Technologies, Inc.","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.199278+00:00","generated_at":"2026-05-30T10:38:31.518374+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AirSculpt prelim Q3 revenue $42.5M, down 9% YoY; narrows FY2024 revenue guidance to $183-189M","bullets":["Q3 revenue ~$42.5M, down ~9% YoY; same-store cases declined 8.1%, improving from Q2's 14% drop.","FY2024 revenue guidance narrowed to $183-189M from prior $180-190M; Adjusted EBITDA guidance reaffirmed at $23-28M.","Opened four de novo centers in Q3; fifth new center expected to open in coming weeks.","Q3 full earnings release and conference call scheduled for November 8, 2024 at 8:00 a.m. ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001870940-24-000041","json":"https://secwatch.observer/filing/0001870940-24-000041.json","markdown":"https://secwatch.observer/filing/0001870940-24-000041.md","text":"https://secwatch.observer/filing/0001870940-24-000041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870940/000187094024000041/0001870940-24-000041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870940/000187094024000041/airs-20241024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:38:31.518374+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}